Abstract
We constructed an immunotoxin, composed of an antibody directed against the high-affinity IgG receptor CD64 and Ricin-A, with the aim of resolving chronic inflammation through elimination of activated macrophages. In vitro, this immunotoxin proved very efficient in inducing apoptosis in activated macrophages, leaving resting and low CD64-expressing macrophages unaffected. We examined the activity of our immunotoxin in a sodium lauryl sulfate (SLS)-induced cutaneous inflammation model, using transgenic mice expressing human CD64. Upon intradermal injection of the immunotoxin (IT), cutaneous inflammation resolved in 24 h. This was demonstrated histologically by clearance of all CD64-expressing macrophages, followed by clearance of other inflammatory cells. Clinical parameters associated with inflammation, such as local skin temperature and vasodilation, also decreased.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Williams, I.R. & Kupper, T.S. Immunity at the surface: homeostatic mechanisms of the skin immune system. Life Sci. 58, 1485–1507 (1996).
Stingl, G. The skin: initiation and target site of immune responses. Recent Results Cancer Res. 128, 45–57 (1993).
Ganz, T. Macrophage function. New Horiz. 1, 23– 27 (1993).
Gordon, S. The macrophage. Bioessays 17, 977– 986 (1995).
Thepen, T., Kraal, G. & Holt, P.G. The role of alveolar macrophages in regulation of lung inflammation. Ann. N. Y. Acad. Sci. 725, 200–206 (1994).
Holt, P.G. et al. Downregulation of the antigen presenting cell function(s) of pulmonary dendritic cells in vivo by resident alveolar macrophages. J. Exp. Med. 177, 397–407 ( 1993).
Strickland, D., Kees, U.R. & Holt, P.G. Regulation of T-cell activation in the lung: alveolar macrophages induce reversible T-cell anergy in vitro associated with inhibition of interleukin-2 receptor signal transduction. Immunology 87, 250–258 ( 1996).
Thepen, T. et al. Biphasic response against aeroallergen in atopic dermatitis showing a switch from an initial TH2 response to a TH1 response in situ: an immunocytochemical study. J. Allergy Clin. Immunol. 97, 828 –837 (1996).
Grewe, M. et al. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis . Immunol. Today 19, 359– 361 (1998).
Avice, M-N. et al. IL-15 promotes IL-12 production by human monocytes via T cell-dependent contact and may contribute to IL-12 mediated IFN-γ secretion by CD4+ T cells in the absence of TCR ligation. J. Immunol. 161, 3408–3415 (1998).
Laskin, D.L. & Pendino, K.J. Macrophages and inflammatory mediators in tissue injury. Annu. Rev. Pharmacol. Toxicol. 35 , 655–677 (1995).
Gonzalez-Ramos, A., Cooper, K.D. & Hammerberg, C. Identification of a human dermal macrophage population responsible for constitutive restraint of primary dermal fibroblast proliferation . J. Invest. Dermatol. 106, 305– 311 (1996).
Deo, Y.M., Graziano, R.F., Repp, R. & van de Winkel, J.G.J. Clinical significance of IgG Fc receptors and Fc gamma R-directed immunotherapies. Immunol. Today 18, 127–135 (1997).
Ravetch, J.V. Fc receptors. Curr. Opin. Immunol. 9, 121 –125 (1997).
Davis, B.H., Bigelow, N.C., Curnutte, J.T. & Ornvold, K. Neutrophil CD64 expression: potential diagnostic indicator of acute inflammation and therapeutic monitor of interferon gamma therapy. Lab. Hematol. 1, 3–9 (1995 ).
Guyre, P.M., Morganelli, P.M. & Miller, R. Recombinant immune interferon increases immunoglobulin G Fc receptors on cultured human mononuclear phagocytes. J. Clin. Invest. 72, 393–397 ( 1983).
Heijnen, I.A. et al. Antigen targeting to myeloid-specific human Fc gamma RI/CD64 triggers enhanced antibody responses in transgenic mice. J. Clin. Invest. 97, 331–338 ( 1996).
Trush, G.R., Lark, L.R., Clinchy, B.C. & Vitetta, E.S. Immunotoxins: an update. Ann. Rev. Immunol. 14, 49–71 (1996).
Guyre, P.M., Graziano, R.F., Vance, B.A., Morganelli, P.M. & Fanger, M.W. Monoclonal antibodies that bind to distinct epitopes on Fc gamma RI are able to trigger receptor function . J. Immunol. 143, 1650– 1655 (1989).
Graziano, R.F. et al. Construction and characterization of a humanized anti-gamma-Ig receptor type I (Fc gamma RI) monoclonal antibody. J. Immunol. 155, 4996–5002 ( 1995).
van Vugt, M.J., van der Herik-Oudijk, I.E., & van de Winkel, J.G.J. Fc gamma RIa/gamma-chain complexes trigger antibody-dependent cell-mediated cytotoxicity (ADCC) in CD5+ B cell/macrophage IIA1.6 cells. Clin. Exp. Immunol. 113, 415 –422 (1998).
Post, J., Vooys, W.C., de Gast, G.C. & Bast, B.J. Comparison of various in vitro assays for efficacy screening of immunotoxins . Leuk. Res. 19, 241–247 (1995).
Nicoletti, I., Migliorati, G., Pagliacci, M.C., Grignani, F. & Riccardi, C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 139, 271–279 (1991).
Kraal, G., Rep, M. & Janse, M. Macrophages in T and B cell compartments and other tissue macrophages recognized by monoclonal antibody MOMA-2. An immunohistochemical study. Scand. J. Immunol. 26, 653–661 (1987).
Kraal, G., Breel, M., Janse, M. & Bruin, G. Langerhans' cells, veiled cells, and interdigitating cells in the mouse recognized by a monoclonal antibody. J. Exp. Med. 163, 981– 997 (1986).
Tomonari, K. A rat antibody against a structure functionally related to the mouse T-cell receptor/T3 complex. Immunogenetics 28 , 455–458 (1988).
Acknowledgements
The authors wish to thank Drs C.A.F.M. Bruijnzeel-Koomen and K.D. Cooper for helpful discussion, Dr C. Somasundaram for skillful preparation of the immunotoxins, and Tom O'Toole for proofreading the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Thepen, T., van Vuuren, A., Kiekens, R. et al. Resolution of cutaneous inflammation after local elimination of macrophages . Nat Biotechnol 18, 48–51 (2000). https://doi.org/10.1038/71908
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/71908
This article is cited by
-
RvD1 accelerates the resolution of inflammation by promoting apoptosis of the recruited macrophages via the ALX/FasL-FasR/caspase-3 signaling pathway
Cell Death Discovery (2021)
-
Assessment of acute and repeated pulmonary toxicities of oligo(2-(2-ethoxy)ethoxyethyl guanidium chloride in mice
Toxicological Research (2021)
-
Evaluation of Hydra HALT-1 as a toxin moiety for recombinant immunotoxin
BMC Biotechnology (2020)
-
Human CD64-targeted non-viral siRNA delivery system for blood monocyte gene modulation
Scientific Reports (2017)
-
Fully human MAP‐fusion protein selectively targets and eliminates proliferating CD64+ M1 macrophages
Immunology & Cell Biology (2016)